Shopping Cart 0
Cart Subtotal
USD 0

Karo Pharma AB (KARO) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375

Details

Karo Pharma AB (KARO)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Karo Pharma AB (Karo Pharma), formerly Karo Bio AB, is a health care company that focuses on research and development of pharmaceutical products in the areas of cancer and autoimmune diseases. Its key research area involves nuclear receptors as target proteins for the development of new pharmaceuticals. Karo Pharma discovers drugs to target major diseases including autoimmune diseases such as multiple sclerosis; and multiple types of cancer, viral and bacterial infections. The company's projects are based on ROR gamma receptor and estrogen receptor. Its development pipeline also includes T268A Cold Spray which utilizes glucose oxidase enzyme in combination with glucose to fight against cold virus. Karo Pharma is headquartered in Huddinge, Stockholm, Sweden.

Karo Pharma AB Key Recent Developments

Aug 14,2019: Jon Johnsson appointed new CFO of Karo Pharma

Jul 19,2019: Karo Pharma: Interim report January-June 2019

Jul 19,2019: Clarification of the statement in the interim report published 19 July 2019 regarding the rights issue with pre-emptive rights

Apr 26,2019: Karo Pharma: Interim report the first quarter 2019

Apr 03,2019: Karo Pharma Aktiebolag names Christoffer Lorenzen as CEO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Karo Pharma AB-Key Facts

Karo Pharma AB-Key Employees

Karo Pharma AB-Key Employee Biographies

Karo Pharma AB-Major Products and Services

Karo Pharma AB-History

Karo Pharma AB-Company Statement

Karo Pharma AB-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Karo Pharma AB-Business Description

Business Segment: OTC (Over the counter) products

Overview

Performance

Business Segment: Other health related products

Overview

Performance

Business Segment: Rx (prescription pharmaceuticals)

Overview

Performance

Geographical Segment: Denmark

Performance

Geographical Segment: Europe

Performance

Geographical Segment: Finland

Performance

Geographical Segment: Iceland

Performance

Geographical Segment: Norway

Performance

Geographical Segment: Rest of world

Performance

Geographical Segment: Sweden

Performance

Geographical Segment: US

Performance

R&D Overview

Karo Pharma AB-Corporate Strategy

Karo Pharma AB-SWOT Analysis

SWOT Analysis-Overview

Karo Pharma AB-Strengths

Karo Pharma AB-Weaknesses

Karo Pharma AB-Opportunities

Karo Pharma AB-Threats

Karo Pharma AB-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences, Oil & Gas Financial Deals and Alliances

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Karo Pharma AB, Recent Deals Summary

Section 5-Company's Recent Developments

Aug 14, 2019: Jon Johnsson appointed new CFO of Karo Pharma

Jul 19, 2019: Karo Pharma: Interim report January-June 2019

Jul 19, 2019: Clarification of the statement in the interim report published 19 July 2019 regarding the rights issue with pre-emptive rights

Apr 26, 2019: Karo Pharma: Interim report the first quarter 2019

Apr 03, 2019: Karo Pharma Aktiebolag names Christoffer Lorenzen as CEO

Feb 14, 2019: Karo Pharma: Year end report 2018

Jul 19, 2018: Karo pharma triples sales and profit in the second quarter

Apr 26, 2018: Karo Pharma Doubles Sales and Earnings in the First Quarter

Mar 23, 2018: Karo Pharma Supports Operation Smile

Feb 22, 2018: Karo Pharma: Year-end Report 2017

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Karo Pharma AB, Performance Chart (2014-2018)

Karo Pharma AB, Ratio Charts

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Karo Pharma AB, Key Facts

Karo Pharma AB, Key Employees

Karo Pharma AB, Key Employee Biographies

Karo Pharma AB, Major Products and Services

Karo Pharma AB, History

Karo Pharma AB, Subsidiaries

Karo Pharma AB, Key Competitors

Karo Pharma AB, Ratios based on current share price

Karo Pharma AB, Annual Ratios

Karo Pharma AB, Annual Ratios (Cont...1)

Karo Pharma AB, Annual Ratios (Cont...2)

Karo Pharma AB, Interim Ratios

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Karo Pharma AB, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Karo Pharma AB, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Nuevolution AB

Meda AB

Genmab A/S

Dyax Corp

BioInvent International AB

Active Biotech AB

Karo Pharma AB (KARO)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Karo Pharma AB (Karo Pharma), formerly Karo Bio AB, is a health care company that focuses on research and development of pharmaceutical products in the areas of cancer and autoimmune diseases. Its key research area involves nuclear receptors as target proteins for the development of new pharmaceuticals. Karo Pharma discovers drugs to target major diseases including autoimmune diseases such as multiple sclerosis; and multiple types of cancer, viral and bacterial infections. The company's projects are based on ROR gamma receptor and estrogen receptor. Its development pipeline also includes T268A Cold Spray which utilizes glucose oxidase enzyme in combination with glucose to fight against cold virus. Karo Pharma is headquartered in Huddinge, Stockholm, Sweden.

Karo Pharma AB Key Recent Developments

Aug 14,2019: Jon Johnsson appointed new CFO of Karo Pharma

Jul 19,2019: Karo Pharma: Interim report January-June 2019

Jul 19,2019: Clarification of the statement in the interim report published 19 July 2019 regarding the rights issue with pre-emptive rights

Apr 26,2019: Karo Pharma: Interim report the first quarter 2019

Apr 03,2019: Karo Pharma Aktiebolag names Christoffer Lorenzen as CEO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Karo Pharma AB-Key Facts

Karo Pharma AB-Key Employees

Karo Pharma AB-Key Employee Biographies

Karo Pharma AB-Major Products and Services

Karo Pharma AB-History

Karo Pharma AB-Company Statement

Karo Pharma AB-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Karo Pharma AB-Business Description

Business Segment: OTC (Over the counter) products

Overview

Performance

Business Segment: Other health related products

Overview

Performance

Business Segment: Rx (prescription pharmaceuticals)

Overview

Performance

Geographical Segment: Denmark

Performance

Geographical Segment: Europe

Performance

Geographical Segment: Finland

Performance

Geographical Segment: Iceland

Performance

Geographical Segment: Norway

Performance

Geographical Segment: Rest of world

Performance

Geographical Segment: Sweden

Performance

Geographical Segment: US

Performance

R&D Overview

Karo Pharma AB-Corporate Strategy

Karo Pharma AB-SWOT Analysis

SWOT Analysis-Overview

Karo Pharma AB-Strengths

Karo Pharma AB-Weaknesses

Karo Pharma AB-Opportunities

Karo Pharma AB-Threats

Karo Pharma AB-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences, Oil & Gas Financial Deals and Alliances

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Karo Pharma AB, Recent Deals Summary

Section 5-Company's Recent Developments

Aug 14, 2019: Jon Johnsson appointed new CFO of Karo Pharma

Jul 19, 2019: Karo Pharma: Interim report January-June 2019

Jul 19, 2019: Clarification of the statement in the interim report published 19 July 2019 regarding the rights issue with pre-emptive rights

Apr 26, 2019: Karo Pharma: Interim report the first quarter 2019

Apr 03, 2019: Karo Pharma Aktiebolag names Christoffer Lorenzen as CEO

Feb 14, 2019: Karo Pharma: Year end report 2018

Jul 19, 2018: Karo pharma triples sales and profit in the second quarter

Apr 26, 2018: Karo Pharma Doubles Sales and Earnings in the First Quarter

Mar 23, 2018: Karo Pharma Supports Operation Smile

Feb 22, 2018: Karo Pharma: Year-end Report 2017

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Karo Pharma AB, Performance Chart (2014-2018)

Karo Pharma AB, Ratio Charts

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Karo Pharma AB, Key Facts

Karo Pharma AB, Key Employees

Karo Pharma AB, Key Employee Biographies

Karo Pharma AB, Major Products and Services

Karo Pharma AB, History

Karo Pharma AB, Subsidiaries

Karo Pharma AB, Key Competitors

Karo Pharma AB, Ratios based on current share price

Karo Pharma AB, Annual Ratios

Karo Pharma AB, Annual Ratios (Cont...1)

Karo Pharma AB, Annual Ratios (Cont...2)

Karo Pharma AB, Interim Ratios

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Karo Pharma AB, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Karo Pharma AB, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Nuevolution AB

Meda AB

Genmab A/S

Dyax Corp

BioInvent International AB

Active Biotech AB